Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Queensland Health
McKesson
Chinese Patent Office
Johnson and Johnson
AstraZeneca
Teva
Farmers Insurance
Argus Health
Fish and Richardson

Generated: February 23, 2018

DrugPatentWatch Database Preview

ARGATROBAN Drug Profile

« Back to Dashboard

Which patents cover Argatroban, and when can generic versions of Argatroban launch?

Argatroban is a drug marketed by Amneal Pharms Co, Fresenius Kabi Usa, Hikma Pharm Co Ltd, Hospira Inc, Mylan Institutional, Novartis Pharms Corp, Par Sterile Products, Teva Pharms Usa, Sandoz, Eagle Pharms, and Gland Pharma Ltd. and is included in twelve NDAs. There are two patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in ARGATROBAN is argatroban. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the argatroban profile page.

US Patents and Regulatory Information for ARGATROBAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms Co ARGATROBAN argatroban INJECTABLE;INJECTION 206698-001 Jan 26, 2018 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp ARGATROBAN argatroban INJECTABLE;INJECTION 020883-001 Jun 30, 2000 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma Pharm Co Ltd ARGATROBAN argatroban INJECTABLE;INJECTION 203049-001 Jan 5, 2012 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Eagle Pharms ARGATROBAN IN SODIUM CHLORIDE argatroban INJECTABLE;IV (INFUSION) 022434-001 Jun 29, 2011 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Par Sterile Products ARGATROBAN argatroban INJECTABLE;INJECTION 091665-001 Jun 30, 2014 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz ARGATROBAN IN SODIUM CHLORIDE argatroban INJECTABLE;IV (INFUSION) 022485-001 May 9, 2011 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa ARGATROBAN argatroban INJECTABLE;INJECTION 201811-001 Mar 23, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hikma Pharm Co Ltd ARGATROBAN argatroban INJECTABLE;INJECTION 203049-002 Sep 30, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional ARGATROBAN argatroban INJECTABLE;INJECTION 202626-001 Jun 30, 2014 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira Inc ARGATROBAN argatroban INJECTABLE;INJECTION 204120-001 Sep 21, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ARGATROBAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis Pharms Corp ARGATROBAN argatroban INJECTABLE;INJECTION 020883-001 Jun 30, 2000 ➤ Sign Up ➤ Sign Up
Novartis Pharms Corp ARGATROBAN argatroban INJECTABLE;INJECTION 020883-001 Jun 30, 2000 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for ARGATROBAN
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Injection 1 mg/mL, 50 mL vials ➤ Subscribe 12/16/2011
➤ Subscribe Injection 100 mg/mL, 2.5 mL vials ➤ Subscribe 9/24/2007

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Accenture
Covington
Fish and Richardson
Queensland Health
Cerilliant
Argus Health
Citi
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot